| 1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
STAT6 |
| 2 |
34528236 |
10.1111/bjd.20760 |
2022 |
Transcriptomic changes during stage progression of mycosis fungoides. |
STAT6 |
| 3 |
34839096 |
10.1016/j.prp.2021.153697 |
2022 |
STAT6 and phosphorylated STAT6 are differentially expressed in lymphomas. |
STAT6 |
| 4 |
34957565 |
10.1002/path.5861 |
2022 |
Widespread in situ follicular neoplasia in patients who subsequently developed follicular lymphoma. |
STAT6 |
| 5 |
35045920 |
10.1691/ph.2022.1670 |
2022 |
Anti-TIM1 suppresses airway inflammation and hyperresponsiveness via the STAT6 /STAT1 pathways in mice with allergic asthma. |
STAT6 |
| 6 |
35121362 |
10.1016/j.prp.2022.153781 |
2022 |
Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma. |
STAT6 |
| 7 |
35363872 |
10.1182/bloodadvances.2021005284 |
2022 |
Molecular subclusters of follicular lymphoma: a report from the UK's Haematological Malignancy Research Network. |
STAT6 |
| 8 |
35403270 |
10.1111/his.14660 |
2022 |
Intraindividual variability of CD30 expression in mycosis fungoides -implications for diagnostic evaluation and therapy. |
STAT6 |
| 9 |
35795062 |
10.3389/fonc.2022.870487 |
2022 |
Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis. |
STAT6 |
| 10 |
35816682 |
10.1182/bloodadvances.2022008355 |
2022 |
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared to stage III/IV. |
STAT6 |
| 11 |
35851155 |
10.1038/s41375-022-01641-x |
2022 |
PARP14 is a novel target in STAT6 mutant follicular lymphoma. |
STAT6 |
| 12 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
STAT6 |
| 13 |
35973369 |
10.1016/j.intimp.2022.109138 |
2022 |
Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization. |
STAT6 |
| 14 |
35989611 |
10.1080/13685538.2022.2110232 |
2022 |
Solitary fibrous tumors in prostate: a case report with review of the literature. |
STAT6 |
| 15 |
35999655 |
10.1093/asj/sjac234 |
2022 |
CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant Associated Anaplastic Large Cell Lymphoma. |
STAT6 |
| 16 |
36001451 |
10.1097/PAS.0000000000001956 |
2022 |
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. |
STAT6 |
| 17 |
36074181 |
10.1007/s00277-022-04949-x |
2022 |
Circulating tumor DNA in Hodgkin lymphoma. |
STAT6 |
| 18 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
STAT6 |
| 19 |
32600091 |
10.1080/15592294.2020.1786317 |
2021 |
Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma. |
STAT6 |
| 20 |
32954856 |
10.1080/17425247.2021.1825376 |
2021 |
Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action. |
STAT6 |
| 21 |
33150420 |
10.1182/blood.2020005083 |
2021 |
Plasmablasts derive from CD23- activated B cells after the extinction of IL-4/STAT6 signaling and IRF4 induction. |
STAT6 |
| 22 |
33507341 |
10.1007/s00262-020-02835-x |
2021 |
Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis. |
STAT6 |
| 23 |
33672548 |
10.3390/cancers13040884 |
2021 |
Biology and Clinical Applicability of Plasma Thymus and Activation-Regulated Chemokine (TARC) in Classical Hodgkin Lymphoma. |
STAT6 |
| 24 |
33684939 |
10.1182/blood.2020007683 |
2021 |
Characterization of DLBCL with a PMBL gene expression signature. |
STAT6 |
| 25 |
33777766 |
10.3389/fonc.2021.620435 |
2021 |
Case Report: Multiple Chromosomal Translocations Including Novel CIITA-CREBBP Fusion and Mutations in a Follicular Lymphoma. |
STAT6 |
| 26 |
33945543 |
10.1371/journal.pone.0248886 |
2021 |
Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes. |
STAT6 |
| 27 |
33991851 |
10.1016/j.prp.2021.153477 |
2021 |
STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology. |
STAT6 |
| 28 |
34090412 |
10.1186/s12890-021-01553-z |
2021 |
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation. |
STAT6 |
| 29 |
34312841 |
10.1111/bjh.17719 |
2021 |
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. |
STAT6 |
| 30 |
34359628 |
10.3390/cancers13153724 |
2021 |
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients. |
STAT6 |
| 31 |
34388250 |
10.1093/jnen/nlab080 |
2021 |
Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas. |
STAT6 |
| 32 |
34778251 |
10.3389/fcell.2021.735855 |
2021 |
A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint. |
STAT6 |
| 33 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
STAT6 |
| 34 |
34926078 |
10.7759/cureus.19614 |
2021 |
Gastric Desmoid Fibromatosis - Report of a Rare Mimic of Gastrointestinal Stromal Tumor. |
STAT6 |
| 35 |
34945004 |
10.3390/cancers13246384 |
2021 |
Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel. |
STAT6 |
| 36 |
31524297 |
10.1002/hon.2679 |
2020 |
STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma. |
STAT6 |
| 37 |
31688142 |
10.1097/PAS.0000000000001399 |
2020 |
Unusual Variants of Follicular Lymphoma: Case-based Review. |
STAT6 |
| 38 |
31822802 |
10.1038/s41379-019-0428-0 |
2020 |
Diagnostic utility of STAT6<sup>YE361</sup> expression in classical Hodgkin lymphoma and related entities. |
STAT6 |
| 39 |
32438399 |
10.1182/blood.2019004725 |
2020 |
Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma. |
STAT6 |
| 40 |
32506320 |
10.1007/s12185-020-02901-1 |
2020 |
Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation. |
STAT6 |
| 41 |
32514881 |
10.1007/s11748-020-01396-1 |
2020 |
A case of long-term unchanged calcifying fibrous tumor. |
STAT6 |
| 42 |
32555149 |
10.1038/s41408-020-0335-0 |
2020 |
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. |
STAT6 |
| 43 |
32643174 |
10.1111/ijd.15036 |
2020 |
Mapping signal transducer and activator of transcription (STAT) activity in different stages of mycosis fungoides and Sezary syndrome. |
STAT6 |
| 44 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
STAT6 |
| 45 |
33144480 |
10.21873/invivo.12211 |
2020 |
Solitary Fibrous Tumor of the Orbit: A Clinicopathologic Study of Two Cases With Review of the Literature. |
STAT6 |
| 46 |
33149660 |
10.2147/IJGM.S279483 |
2020 |
Intracranial Primary Malignant Solitary Fibrous Tumor/Hemangiopericytoma Masquerading as Meningioma: Report of a Rare Case. |
STAT6 |
| 47 |
33188464 |
10.1186/s40792-020-01067-6 |
2020 |
Malignant solitary fibrous tumor of the pancreas: a case report. |
STAT6 |
| 48 |
33211828 |
10.1182/bloodadvances.2020002944 |
2020 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. |
STAT6 |
| 49 |
30338340 |
10.1007/s00125-018-4750-8 |
2019 |
The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes. |
STAT6 |
| 50 |
30381301 |
10.3324/haematol.2018.201590 |
2019 |
TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation <i>via</i> NF-κB mediated signaling in B-cells. |
STAT6 |
| 51 |
30696620 |
10.1182/blood-2018-08-871293 |
2019 |
Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma. |
STAT6 |
| 52 |
30962205 |
10.1182/blood.2018880138 |
2019 |
Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells. |
STAT6 |
| 53 |
31568628 |
10.1111/jcmm.14653 |
2019 |
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. |
STAT6 |
| 54 |
31718693 |
10.1186/s13046-019-1428-0 |
2019 |
Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6. |
STAT6 |
| 55 |
31816062 |
10.1182/bloodadvances.2019001012 |
2019 |
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. |
STAT6 |
| 56 |
29193015 |
10.1111/bjh.15041 |
2018 |
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion. |
STAT6 |
| 57 |
29238954 |
10.1111/bjd.16237 |
2018 |
Interleukin-25 is involved in cutaneous T-cell lymphoma progression by establishing a T helper 2-dominant microenvironment. |
STAT6 |
| 58 |
29449275 |
10.1182/blood-2017-11-812073 |
2018 |
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. |
STAT6 |
| 59 |
29501729 |
10.1016/j.cellsig.2018.02.016 |
2018 |
STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma. |
STAT6 |
| 60 |
29650799 |
10.1182/blood-2017-11-814913 |
2018 |
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. |
STAT6 |
| 61 |
29651360 |
10.1186/s40164-018-0100-2 |
2018 |
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. |
STAT6 |
| 62 |
29656114 |
10.1016/j.exphem.2018.04.002 |
2018 |
Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1. |
STAT6 |
| 63 |
29695237 |
10.1186/s12885-018-4266-0 |
2018 |
Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation. |
STAT6 |
| 64 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
STAT6 |
| 65 |
30107911 |
10.1016/j.bbrc.2018.08.030 |
2018 |
IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation. |
STAT6 |
| 66 |
28082443 |
10.1182/blood-2016-06-720516 |
2017 |
A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells. |
STAT6 |
| 67 |
28099521 |
10.1371/journal.ppat.1006124 |
2017 |
Nuclear Localization and Cleavage of STAT6 Is Induced by Kaposi's Sarcoma-Associated Herpesvirus for Viral Latency. |
STAT6 |
| 68 |
28875978 |
10.1038/icb.2017.71 |
2017 |
IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation. |
STAT6 |
| 69 |
26474728 |
10.1002/eji.201545673 |
2016 |
Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production. |
STAT6 |
| 70 |
26647218 |
10.1158/1078-0432.CCR-15-2123 |
2016 |
Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas. |
STAT6 |
| 71 |
26811457 |
10.1073/pnas.1524668113 |
2016 |
Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma. |
STAT6 |
| 72 |
26965583 |
10.1038/modpathol.2016.51 |
2016 |
Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations. |
STAT6 |
| 73 |
27398157 |
|
2016 |
Flagellin modulates IgE expression in B cells to initiate food allergy in mice. |
STAT6 |
| 74 |
27440511 |
10.1373/clinchem.2016.255315 |
2016 |
Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma. |
STAT6 |
| 75 |
25428220 |
10.1182/blood-2014-06-582650 |
2015 |
Activating STAT6 mutations in follicular lymphoma. |
STAT6 |
| 76 |
25614636 |
10.1182/blood-2014-12-615294 |
2015 |
Mutations and microenvironment collude in FL. |
STAT6 |
| 77 |
26112603 |
10.1016/j.febslet.2015.06.015 |
2015 |
E3 ubiquitin ligase Cbl-b suppresses human ORMDL3 expression through STAT6 mediation. |
STAT6 |
| 78 |
26123794 |
10.1016/j.blre.2015.06.002 |
2015 |
Deregulated JAK/STAT signalling in lymphomagenesis, and its implications for the development of new targeted therapies. |
STAT6 |
| 79 |
26246572 |
10.1128/JVI.01525-15 |
2015 |
Constitutive Activation of Interleukin-13/STAT6 Contributes to Kaposi's Sarcoma-Associated Herpesvirus-Related Primary Effusion Lymphoma Cell Proliferation and Survival. |
STAT6 |
| 80 |
26438862 |
10.1073/pnas.1407075112 |
2015 |
Effects of lymphocyte profile on development of EBV-induced lymphoma subtypes in humanized mice. |
STAT6 |
| 81 |
26461141 |
10.3892/mmr.2015.4411 |
2015 |
MicroRNA‑361‑5p suppresses cancer progression by targeting signal transducer and activator of transcription 6 in non‑small cell lung cancer. |
STAT6 |
| 82 |
26565811 |
10.18632/oncotarget.6300 |
2015 |
Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma. |
STAT6 |
| 83 |
24491557 |
10.1016/j.bbrc.2014.01.140 |
2014 |
MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6). |
STAT6 |
| 84 |
24550509 |
10.1073/pnas.1301138111 |
2014 |
Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression. |
STAT6 |
| 85 |
24610827 |
10.1158/1078-0432.CCR-13-3007 |
2014 |
Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo. |
STAT6 |
| 86 |
24886089 |
10.1186/1476-4598-13-125 |
2014 |
DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells. |
STAT6 |
| 87 |
24908303 |
10.1007/978-1-4939-0928-5_14 |
2014 |
Evaluation of the adverse effect of low concentration of cadmium on interleukin-4 induced class switch recombination in Burkett's lymphoma Raji cell line. |
STAT6 |
| 88 |
24960198 |
10.1016/j.bbrc.2014.06.069 |
2014 |
IL-4 receptor α in non-lipid rafts is the target molecule of strictinin in inhibiting STAT6 activation. |
STAT6 |
| 89 |
24965443 |
10.1111/bjh.12997 |
2014 |
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG). |
STAT6 |
| 90 |
25193702 |
10.1016/j.bbrc.2014.08.131 |
2014 |
Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. |
STAT6 |
| 91 |
25277174 |
10.18632/oncotarget.2447 |
2014 |
Targeting STAT6 in PMBL. |
STAT6 |
| 92 |
25485578 |
10.4161/15384101.2014.965061 |
2014 |
Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression. |
STAT6 |
| 93 |
25486484 |
10.4161/15384101.2014.947759 |
2014 |
Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. |
STAT6 |
| 94 |
25594020 |
10.18632/oncoscience.35 |
2014 |
Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents. |
STAT6 |
| 95 |
23297127 |
10.1182/blood-2012-04-421826 |
2013 |
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. |
STAT6 |
| 96 |
23553437 |
10.1002/ijc.28189 |
2013 |
Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs. |
STAT6 |
| 97 |
23768868 |
10.1016/j.leukres.2013.05.003 |
2013 |
Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma. |
STAT6 |
| 98 |
23852366 |
10.18632/oncotarget.1149 |
2013 |
STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL). |
STAT6 |
| 99 |
23940785 |
10.1371/journal.pone.0071754 |
2013 |
Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models. |
STAT6 |
| 100 |
22012462 |
10.1099/vir.0.036087-0 |
2012 |
Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein. |
STAT6 |
Datasets
Models
